TWEAK and cIAP1 regulate myoblast fusion through the noncanonical NF-κB signaling pathway (Q39257705)

10 September 2017

TWEAK and cIAP1 regulate myoblast fusion through the noncanonical NF-κB signaling pathway (English)

1 reference

10 September 2017

0 references

0 references

Emeka K Enwere

1

1 reference

10 September 2017

Janelle Holbrook

2

1 reference

10 September 2017

Rim Lejmi-Mrad

3

1 reference

10 September 2017

Jennifer Vineham

4

1 reference

10 September 2017

Kristen Timusk

5

1 reference

10 September 2017

Baktharaman Sivaraj

6

1 reference

10 September 2017

Methvin Isaac

7

1 reference

10 September 2017

David Uehling

8

1 reference

10 September 2017

Rima Al-awar

9

1 reference

10 September 2017

Eric LaCasse

10

1 reference

10 September 2017

Robert G Korneluk

11

1 reference

10 September 2017

16 October 2012

1 reference

10 September 2017

1 reference

10 September 2017

5

1 reference

10 September 2017

ra75

1 reference

10 September 2017

246

1 reference

Myoblast fusion: lessons from flies and mice

10 September 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

IAP-targeted therapies for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Smac mimetics activate the E3 ligase activity of cIAP1 protein by promoting RING domain dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Antagonists induce a conformational change in cIAP1 that promotes autoubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Cellular inhibitors of apoptosis are global regulators of NF-κB and MAPK activation by members of the TNF family of receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

RelB cellular regulation and transcriptional activity are regulated by p100.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

IKK/NF-kappaB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

TNFalpha inhibits skeletal myogenesis through a PW1-dependent pathway by recruitment of caspase pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

IL-1beta impairs insulin-like growth factor i-induced differentiation and downstream activation signals of the insulin-like growth factor i receptor in myoblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-kappaB-inducing kinase and p38 mitogen-activated protein kinase: a potential r

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-kappaB and degradation of MyoD protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Nuclear factor kappa B-inducing kinase and Ikappa B kinase-alpha signal skeletal muscle cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

CHFR, a potential tumor suppressor, downregulates interleukin-8 through the inhibition of NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

A novel role for RIP1 kinase in mediating TNFα production

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Fibroblast growth factor inducible 14 (Fn14) is required for the expression of myogenic regulatory factors and differentiation of myoblasts into myotubes. Evidence for TWEAK-independent functions of Fn14 during myogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Tumor necrosis factor (TNF) signaling, but not TWEAK (TNF-like weak inducer of apoptosis)-triggered cIAP1 (cellular inhibitor of apoptosis protein 1) degradation, requires cIAP1 RING dimerization and E2 binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. Evidence for a second TWEAK receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Mitogen-activated protein kinase pathway is involved in the differentiation of muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

MEK1 plays contrary stage-specific roles in skeletal myogenic differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

ERK2 is required for efficient terminal differentiation of skeletal myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

MAP kinase phosphatase-1 deficiency impairs skeletal muscle regeneration and exacerbates muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Molecular control of mammalian myoblast fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Identification of FHL1 as a regulator of skeletal muscle mass: implications for human myopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

IKKα and alternative NF-κB regulate PGC-1β to promote oxidative muscle metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

TNF inhibits Notch-1 in skeletal muscle cells by Ezh2 and DNA methylation mediated repression: implications in duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

S100B in myoblasts regulates the transition from activation to quiescence and from quiescence to activation and reduces apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

NF-kappaB regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myofibrillar genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Glutathione depletion impairs myogenic differentiation of murine skeletal muscle C2C12 cells through sustained NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Single-cell NF-kappaB dynamics reveal digital activation and analogue information processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Information transduction capacity of noisy biochemical signaling networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Polyfunctional responses by human T cells result from sequential release of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

A noisy paracrine signal determines the cellular NF-kappaB response to lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

TNF-like weak inducer of apoptosis (TWEAK) activates proinflammatory signaling pathways and gene expression through the activation of TGF-beta-activated kinase 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Genetic ablation of TWEAK augments regeneration and post-injury growth of skeletal muscle in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Role of TNF-{alpha} signaling in regeneration of cardiotoxin-injured muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

TNF-alpha regulates myogenesis and muscle regeneration by activating p38 MAPK

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

TWEAK causes myotube atrophy through coordinated activation of ubiquitin-proteasome system, autophagy, and caspases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Cloning and characterization of the rat homologues of the Inhibitor of Apoptosis protein 1, 2, and 3 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Design, synthesis, and characterization of a potent, nonpeptide, cell-permeable, bivalent Smac mimetic that concurrently targets both the BIR2 and BIR3 domains in XIAP

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Mono- and bis-thiazolium salts have potent antimalarial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

Donor-acceptor (electronic) coupling in the precursor complex to organic electron transfer: intermolecular and intramolecular self-exchange between phenothiazine redox centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003086

10.1126/SCISIGNAL.2003086

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference